Rigel Pharmaceuticals Stock Price History
| RIGL Stock | USD 20.20 0.17 0.83% |
Below is the normalized historical share price chart for Rigel Pharmaceuticals extending back to November 29, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Rigel Pharmaceuticals stands at 20.20, as last reported on the 21st of March, with the highest price reaching 20.54 and the lowest price hitting 19.87 during the day.
If you're considering investing in Rigel Stock, it is important to understand the factors that can impact its price. Rigel Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Rigel Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0828, which implies the firm had a 0.0828 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Rigel Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Rigel Pharmaceuticals' Risk Adjusted Performance of 0.0479, semi deviation of 3.6, and Coefficient Of Variation of 2218.77 to confirm if our risk estimates are consistent with your expectations.
Common Stock Total Equity is expected to rise to about 210.1 K this year, although the value of Total Stockholder Equity will most likely fall to about 3.1 M. . At this time, Rigel Pharmaceuticals' Price Cash Flow Ratio is quite stable compared to the past year. Price Fair Value is expected to rise to 94.42 this year, although the value of Price Earnings To Growth Ratio is projected to rise to (0.1). Rigel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of November 2000 | 200 Day MA 16.2172 | 50 Day MA 20.6626 | Beta 1.346 |
Rigel |
Sharpe Ratio = 0.0828
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RIGL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.45 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Rigel Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rigel Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 110.6656 | Enterprise Value Ebitda 12.1532 | Price Sales 2.0296 | Shares Float 15.3 M | Wall Street Target Price 33.6667 |
Rigel Pharmaceuticals Stock Price History Chart
There are several ways to analyze Rigel Stock price data. The simplest method is using a basic Rigel candlestick price chart, which shows Rigel Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 6, 2025 | 24.39 |
| Lowest Price | January 8, 2025 | 16.25 |
Rigel Pharmaceuticals March 21, 2025 Stock Price Synopsis
Various analyses of Rigel Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rigel Stock. It can be used to describe the percentage change in the price of Rigel Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rigel Stock.| Rigel Pharmaceuticals Price Rate Of Daily Change | 0.99 | |
| Rigel Pharmaceuticals Price Daily Balance Of Power | (0.25) | |
| Rigel Pharmaceuticals Price Action Indicator | (0.09) | |
| Rigel Pharmaceuticals Accumulation Distribution | 21,993 |
Rigel Pharmaceuticals March 21, 2025 Stock Price Analysis
Rigel Stock Price History Data
The price series of Rigel Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 8.14 with a coefficient of variation of 10.81. The price distribution for the period has arithmetic mean of 19.88. The median price for the last 90 days is 20.43. The company completed stock split (1:10) on 27th of June 2024.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 20.13 | 20.54 | 19.87 | 20.20 | 674,225 | |
| 03/20/2025 | 20.25 | 21.00 | 20.14 | 20.37 | 239,088 | |
| 03/19/2025 | 20.39 | 20.76 | 19.81 | 20.44 | 112,281 | |
| 03/18/2025 | 20.89 | 21.19 | 20.31 | 20.33 | 103,683 | |
| 03/17/2025 | 20.12 | 21.16 | 19.80 | 21.03 | 208,055 | |
| 03/14/2025 | 20.12 | 20.33 | 19.57 | 20.13 | 156,314 | |
| 03/13/2025 | 20.33 | 20.57 | 19.71 | 19.91 | 146,546 | |
| 03/12/2025 | 19.87 | 20.88 | 19.00 | 20.43 | 195,506 | |
| 03/11/2025 | 19.51 | 19.88 | 18.53 | 19.49 | 288,201 | |
| 03/10/2025 | 20.09 | 20.31 | 18.44 | 19.53 | 343,313 | |
| 03/07/2025 | 19.82 | 20.65 | 19.37 | 20.52 | 184,891 | |
| 03/06/2025 | 20.28 | 20.94 | 19.44 | 19.70 | 237,035 | |
| 03/05/2025 | 20.15 | 21.50 | 19.00 | 20.29 | 581,369 | |
| 03/04/2025 | 22.04 | 22.40 | 21.01 | 22.08 | 263,992 | |
| 03/03/2025 | 23.01 | 23.50 | 21.93 | 22.37 | 251,937 | |
| 02/28/2025 | 21.43 | 23.22 | 21.19 | 23.06 | 276,409 | |
| 02/27/2025 | 22.64 | 22.75 | 21.58 | 21.78 | 211,634 | |
| 02/26/2025 | 21.50 | 22.80 | 21.50 | 22.33 | 264,921 | |
| 02/25/2025 | 21.60 | 21.87 | 20.71 | 21.50 | 132,727 | |
| 02/24/2025 | 20.56 | 22.24 | 20.35 | 21.39 | 224,735 | |
| 02/21/2025 | 21.23 | 21.37 | 20.09 | 20.09 | 129,916 | |
| 02/20/2025 | 20.54 | 21.05 | 20.11 | 20.83 | 98,998 | |
| 02/19/2025 | 20.46 | 21.20 | 20.28 | 20.62 | 142,813 | |
| 02/18/2025 | 21.75 | 21.93 | 20.50 | 20.74 | 172,950 | |
| 02/14/2025 | 20.90 | 21.76 | 20.62 | 21.57 | 194,008 | |
| 02/13/2025 | 20.87 | 21.12 | 20.00 | 20.86 | 130,645 | |
| 02/12/2025 | 20.27 | 20.97 | 20.14 | 20.82 | 168,591 | |
| 02/11/2025 | 21.11 | 21.11 | 20.32 | 20.84 | 186,609 | |
| 02/10/2025 | 21.95 | 22.09 | 20.61 | 21.46 | 217,761 | |
| 02/07/2025 | 24.24 | 24.28 | 21.59 | 21.94 | 231,005 | |
| 02/06/2025 | 23.30 | 24.48 | 23.10 | 24.39 | 1,004,428 | |
| 02/05/2025 | 20.98 | 22.90 | 20.83 | 22.84 | 378,293 | |
| 02/04/2025 | 21.12 | 21.43 | 20.63 | 20.86 | 491,915 | |
| 02/03/2025 | 20.90 | 21.71 | 20.37 | 21.16 | 147,436 | |
| 01/31/2025 | 22.59 | 23.01 | 21.27 | 21.65 | 139,158 | |
| 01/30/2025 | 22.76 | 23.00 | 22.34 | 22.60 | 129,401 | |
| 01/29/2025 | 22.02 | 22.85 | 21.88 | 22.49 | 93,202 | |
| 01/28/2025 | 21.72 | 22.17 | 20.98 | 22.16 | 134,301 | |
| 01/27/2025 | 22.17 | 23.20 | 21.46 | 21.72 | 171,864 | |
| 01/24/2025 | 21.98 | 22.32 | 21.24 | 22.17 | 166,861 | |
| 01/23/2025 | 21.57 | 22.39 | 21.13 | 22.14 | 178,613 | |
| 01/22/2025 | 22.02 | 22.06 | 20.75 | 21.81 | 243,677 | |
| 01/21/2025 | 20.35 | 21.83 | 19.58 | 21.81 | 351,486 | |
| 01/17/2025 | 17.70 | 20.52 | 17.28 | 20.13 | 584,549 | |
| 01/16/2025 | 18.00 | 18.08 | 17.33 | 17.35 | 116,550 | |
| 01/15/2025 | 17.23 | 18.06 | 17.10 | 18.01 | 157,695 | |
| 01/14/2025 | 17.22 | 17.43 | 16.37 | 16.69 | 206,449 | |
| 01/13/2025 | 17.83 | 18.25 | 16.37 | 17.11 | 328,630 | |
| 01/10/2025 | 16.06 | 16.31 | 15.50 | 16.25 | 220,429 | |
| 01/08/2025 | 17.07 | 17.07 | 15.88 | 16.25 | 239,400 | |
| 01/07/2025 | 16.64 | 17.36 | 16.64 | 17.09 | 320,021 | |
| 01/06/2025 | 17.60 | 17.67 | 16.53 | 16.60 | 255,894 | |
| 01/03/2025 | 17.50 | 18.24 | 16.91 | 17.38 | 145,797 | |
| 01/02/2025 | 17.00 | 18.15 | 17.00 | 17.32 | 226,758 | |
| 12/31/2024 | 16.55 | 17.16 | 15.77 | 16.82 | 1,572,942 | |
| 12/30/2024 | 16.35 | 16.86 | 15.61 | 16.47 | 621,542 | |
| 12/27/2024 | 17.27 | 17.27 | 16.17 | 16.50 | 338,790 | |
| 12/26/2024 | 16.44 | 17.36 | 15.98 | 17.26 | 247,600 | |
| 12/24/2024 | 16.82 | 16.82 | 14.63 | 16.44 | 490,880 | |
| 12/23/2024 | 16.95 | 17.21 | 16.38 | 17.15 | 111,301 | |
| 12/20/2024 | 16.85 | 17.76 | 16.85 | 17.09 | 413,263 |
About Rigel Pharmaceuticals Stock history
Rigel Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rigel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rigel Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rigel Pharmaceuticals stock prices may prove useful in developing a viable investing in Rigel Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.7 M | 16.8 M | |
| Net Loss | -67.4 M | -70.7 M |
Rigel Pharmaceuticals Quarterly Net Working Capital |
|
Rigel Pharmaceuticals Stock Technical Analysis
Rigel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Rigel Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rigel Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rigel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rigel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0479 | |||
| Jensen Alpha | 0.333 | |||
| Total Risk Alpha | 0.5447 | |||
| Sortino Ratio | 0.0665 | |||
| Treynor Ratio | 0.0931 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 17.867 | Earnings Share 0.99 | Revenue Per Share | Quarterly Revenue Growth 0.609 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.